Reuters logo
BRIEF-Array Biopharma provides NEMO update
March 19, 2017 / 11:33 PM / 9 months ago

BRIEF-Array Biopharma provides NEMO update

March 19 (Reuters) - Array Biopharma Inc :

* Array Biopharma provides NEMO update

* Array Biopharma Inc - Has withdrawn from U.S. FDA division of oncology products 2 its new drug application (NDA) for binimetinib monotherapy

* Says ongoing clinical trials for binimetinib will continue

* Array Biopharma Inc - Withdrawl will not impact planned Phase 3 columbus trial NDA of binimetinib Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below